Topic

Articles

Expectations for trial design will continue to change, and it’s critical that IRT vendors continue to listen to their customers and evolve their offerings accordingly.

Clinical Trials Are Changing—What Does This Mean For IRT?

The importance of examining this generation’s influence on the clinical trial value chain.

Millennials and their Impact on Clinical Research

Rolf Ehrhardt, MD, PhD is CEO of MedCision.

Automation will be key to improving efficiency and mitigating risk during the complex process of cell therapy production and delivery.

The Success of Cell Therapies Will Depend on Automation

Gaps in the good manufacturing practice controls on medicines for clinical trials are targeted in new rules from the EU.

New Rules for European Investigational Medicines

In this article, MedCision executive discusses cell therapies.

Amy Ripston is Head of Marketing at 4G Clinical.

4G Clinical head of marketing, Amy Ripston interviews Catherine Hall, director of operational excellence, at Sunovion to discuss how IRT bridges the gap between clinical and supply, and how interactive response technologies (IRT) can be leveraged to enable innovative trial designs. 

IRT Bridges Clinical and Supply Together—and Why It Matters

Issues of counterfeit drugs being introduced into a supply chain have been a concern in comparative clinical trials. Terry Walsh of GSK speaks about the addressing this issue and ensuring that comparator drug supplies are more readily available for comparative trials.

TransCelerate’s Comparator Network: Terry Walsh of GSK Discusses Sharing Materials for Comparative Trials

With cell-based therapies possessing multistep supply chains and complex track and trace, logistics management systems can be useful for trials even in the protocol-planning stage.

It’s Never Too Early for Cold Chain Planning for Cell Therapies

Cellular therapies offer potential to improve medicine and fill the needs of patients with few treatment options, though these products must be stored at cryogenic temperatures. Incorporating cold chain logistics into your clinical trial can prove beneficial in making these products available to patients.

It’s Never Too Early for Cold Chain Planning for Cellular Therapies

With all the focus on various data capture solutions in the clinical trials world over the past decade(s), few people seem to have noticed the exponential advances made in the real workhorse systems of the trials: RTSM. Also known as IVR, IWR and IRT, these systems actually execute randomization, blinded supply and resupply management to depots and sites, and most importantly of all, drug dispensing. Is there anything more important to get right?

Clinical Trial Supply Chain